Novozymes to Buy Merck KGaA's Crop BioScience Business for $275 Million

09:58 AM | December 20, 2010 | Alex Scott

Enzymes technology firm Novozymes has agreed to buy Merck KGaA’s (Darmstadt, Germany) Crop BioScience business for $275 million. The firm’s say they expect to complete the transaction at the beginning...